Stanley Plotkin

GeoVax to Participate in International Webinar Focused on the State of COVID-19 Vaccines

Retrieved on: 
Monday, June 29, 2020
Medicine, Medical specialties, Health, Stanley Plotkin, GeoVax, Vaccine, Severe acute respiratory syndrome, Vaccines

The webinar will be held on July 1, 2020 and is sponsored by the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Science.

Key Points: 
  • The webinar will be held on July 1, 2020 and is sponsored by the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Science.
  • During the webinar, Dr. Robinson will speak on the prospects of a SARS-COV-2 vaccine.
  • Also speaking during the webinar will be Stanley Plotkin, MD, a world-renowned vaccine expert and member of GeoVaxs Scientific Advisory Board.
  • GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novelproprietaryvaccine platform (GV-MVA-VLPTM).

Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board

Retrieved on: 
Monday, December 9, 2019
Stanley Plotkin, Wistar Institute, Valneva SE, Plotkin, Philadelphia, Health, Medical specialties

Saint-Herblain (France), December 9, 2019 Valneva SE (Valneva or the Company) today announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB).

Key Points: 
  • Saint-Herblain (France), December 9, 2019 Valneva SE (Valneva or the Company) today announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB).
  • Dr. Stanley A. Plotkin, MD and Dr. Anna Durbin, MD, have joined Valnevas SAB.
  • Dr. Stanley Plotkin serves as a consultant to the vaccine industry and is an emeritus professor at both the Wistar Institute and University of Pennsylvania.
  • Thomas Lingelbach, Chief Executive Officer of Valneva commented, Dr. Plotkin and Dr. Durbin will bring significant expertise to our SAB.

Dr. Paul Offit Receives 2018 Albert B. Sabin Gold Medal

Retrieved on: 
Tuesday, April 24, 2018
Medicine, Vaccination, Health, Poliomyelitis, Paul Offit, Albert Sabin, Albert B. Sabin Gold Medal, Stanley Plotkin, Sabin, Rotavirus vaccine, Albert Kapikian

WASHINGTON, April 24, 2018 /PRNewswire-USNewswire/ --Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Paul Offit with the 2018 Albert B. Sabin Gold Medal.

Key Points: 
  • WASHINGTON, April 24, 2018 /PRNewswire-USNewswire/ --Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Paul Offit with the 2018 Albert B. Sabin Gold Medal.
  • "It's an honor to join the distinguished ranks of Albert B. Sabin Gold Medal recipients," said Dr. Offit.
  • The 2018 Albert B. Sabin Gold Medal ceremony will take place at the National Academy of Sciences building in Washington, D.C. Dr. Offit is the fourth Sabin Gold Medal recipient recognized for medical research contributions to rotavirus vaccines, following Stanley Plotkin, M.D.
  • The 2018 Albert B. Sabin Gold Medal ceremony was made possible in part by the Bill & Melinda Gates Foundation.